Trametinib is a type of MEK inhibitor. It’s really focused on helping treat melanoma with the BRAF V600E/K mutation and NSCLC. It works by stopping the MEK signaling pathway.
You can get it in two doses: 0.5 mg and 2 mg, both in these film-coated tablet forms. They usually suggest 2 mg a day, on an empty stomach if you can. Each bottle comes with 30 tablets to keep you on a steady regimen.
It’s targeting that whole RAS/RAF/MEK/ERK signaling deal, which gets all messed up in many cancers, to slow down cell growth and cancer spread.
Reviews
There are no reviews yet.